Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study

Infection. 2023 Feb;51(1):129-136. doi: 10.1007/s15010-022-01853-4. Epub 2022 Jun 10.


Purpose: This multicenter observational study was done to evaluate risk factors related to the development of BSI in patients admitted to ICU for COVID-19.

Methods: All patients with COVID-19 admitted in two COVID-19 dedicated ICUs in two different hospital between 02-2020 and 02-2021 were recruited.

Result: 537 patients were included of whom 265 (49.3%) experienced at least one BSI. Patients who developed bacteremia had a higher SOFA score [10 (8-12) vs 9 (7-10), p < 0.001], had been intubated more frequently [95.8% vs 75%, p < 0.001] and for a median longer time [16 days (9-25) vs 8 days (5-14), p < 0.001]. Patients with BSI had a median longer ICU stay [18 days (12-31.5) vs 9 days (5-15), p < 0.001] and higher mortality [54% vs 42.3%, p < 0.001] than those who did not develop it. Development of BSI resulted in a higher SOFA score [aHR 1.08 (95% CI 1.03-1.12)] and a higher Charlson score [csAHR 1.15 (95% CI 1.05-1.25)].

Conclusion: A high SOFA score and a high Charlson score resulted associated with BSI's development. Conversely, immunosuppressive therapy like steroids and tocilizumab, has no role in increasing the risk of bacteremia.

Keywords: Bacteremia; COVID-19; Charlson score; Immunosuppressive therapy; SOFA score.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Bacteremia* / epidemiology
  • COVID-19* / complications
  • COVID-19* / epidemiology
  • Cohort Studies
  • Humans
  • Intensive Care Units
  • Retrospective Studies
  • Risk Factors